Artificial Pancreas Device System Market Research Report–Forecast till 2027

Artificial Pancreas Device System Market Research Report by Type (CTR, CTT), End-user (Hospitals, Medical Centers, and Others), and Region (North America, Europe, APAC, RoW)- Forecast to 2027

ID: MRFR/MED/5208-HCR | February 2021 | Region: Global | 100 pages

Artificial Pancreas Device System Market Snapshot


The demand for artificial pancreas devices has increased lately as the cases related to pancreatic ailments and failures have grown substantially. The market is set to attain revenues valued at USD 341.08 million while forging ahead at a CAGR of 21.10% in the upcoming forecast period between 2017 and 2023. The escalating number of cases being diagnosed with diabetes is the key factor in promoting the development of the market. The rising inflow of investment in the market is expected to improve the product quality, thus increasing the sales of the market. As patients these days are more or less aware of the treatment options, they are also increasingly involved in the selection of their treatment options in certain cases. This factor is anticipated to reflect positively in the expansion of the artificial pancreas device system market in the upcoming forecast period.


Report Overview


The market perspective offered by MRFR spans the entire market and gives in-depth coverage of the latest trends that are shaping the future of the artificial pancreas device system market. The report aptly captures the development of the market through current market trends, historical growth analysis, and revenue projections for a period ranging to 2023. The market also mentions CTR (Control to Range) Systems and CTT (Control to Target) Systems. The end user segments such as hospital and medical centers are also significantly emphasized upon, and a detailed analysis of the segments is also presented in the report. The market dynamics related to pricing and feasibility analysis is significantly along with macroeconomic indicators, and feasibility indicators provides a comprehensive overview of the artificial pancreas device system market in the forecast period.


Report Coverage


The report on the artificial pancreas device system market consists of market dynamics, forecast, historical market trends, market value by region as well as by country-level analysis for each market segment, segmentation, market factor analysis and key player’s market share analysis that includes supply chain and Porter’s five forces analysis of the market.


Companies Covered


Medtronic Plc, Bigfoot Biomedical, Johnson & Johnson, Dexcom Inc., Cellnovo, Tandem Diabetes Care Inc., Pancreum Inc., TypeZero Technologies LLC, Beta Bionics, F. Hoffmann-La Roche Ltd, Inreda Diabetic B.V., Insulet Corp


Research Methodology


The progression of research while creating reports at Market Research Future includes highlights and facts that are essential to the expansion of artificial pancreas device system market. The research initiated by our analysts enhances the capability of our clients to outline their vision for growth better. The unification of primary and secondary research approaches in our reports divulges widespread information connected to new revenue pockets and developing markets globally. The report methodology also ensures strategy roadmaps that exhibit a distinct picture of the present trends as well as the trends that can affect the forthcoming development of the artificial pancreas device system market. An intrinsic level of understanding connected to the value chain in a specific market additionally contributes to the value of the reports created by our analysts. Furthermore, the insights into markets, technologies, and industry sectors is positively achieved by the application of top-down and bottom-up approaches.


Segmental Analysis


The segmentation of the artificial pancreas device market has been carried out to better gauge the artificial pancreas device system market.


By Type



  • CTR (Control to Range) Systems

  • CTT (Control To Target) Systems


By End User



  • Hospitals

  • Medical Centers


By Region



  • North America

  • South America

  • Europe

  • Asia-Pacific

  • Middle East

  • Africa



Report Scope:
Report Attribute/Metric Details
  Market Size   2023: 341.08 million
  CAGR   2018-2023: 21.10%
  Base Year   2019
  Forecast Period   2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type, End User and Region
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Medtronic Plc, Bigfoot Biomedical, Johnson & Johnson, Dexcom Inc., Cellnovo, Tandem Diabetes Care Inc., Pancreum Inc., TypeZero Technologies LLC, Beta Bionics, F. Hoffmann-La Roche Ltd, Inreda Diabetic B.V., Insulet Corp
  Key Market Opportunities   Product Manufacturer
  Key Market Drivers

  • Number of cases being diagnosed with diabetes
  • Rising inflow of investment


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :


    The types are included in the artificial pancreas device system market are CTR (Control to Range) Systems, CTT (Control To Target) Systems.

    The major drivers of artificial pancreas device system market are Medtronic Plc, Bigfoot Biomedical, Johnson & Johnson, Dexcom Inc., Cellnovo, Tandem Diabetes Care Inc., Pancreum Inc., TypeZero Technologies LLC, Beta Bionics, F. Hoffmann-La Roche Ltd, Inreda Diabetic B.V., Insulet Corp.

    Artificial Pancreas Device System Market is expected to reach US 341.08 million and at a CAGR 21.10% through 2023.

    The Major driving factor of Artificial Pancreas Device System Market is Number of cases being diagnosed with diabetes.

    Table of Contents:


    Chapter 1. Report Prologue

    Chapter 2. Market Introduction

    2.1 Definition

    2.2 Scope of the Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations

    Chapter 3. Research Methodology

    3.1 Introduction

    3.2 Primary Research

    3.3 Secondary Research

    3.4 Market Size Estimation

    Chapter 4. Market Dynamics

    4.1 Drivers

    4.2 Restraints

    4.3 Opportunities

    4.4 Challenges

    4.5 Macroeconomic Indicators

    4.6 Technology Trends & Assessment

    Chapter 5. Market Factor Analysis

    5.1 Porter’s Five Forces Analysis

    5.1.1 Bargaining Power of Suppliers

    5.1.2 Bargaining Power of Buyers

    5.1.3 Threat of New Entrants

    5.1.4 Threat of Substitutes

    5.1.5 Intensity of Rivalry

    5.2 Value Chain Analysis

    5.3 Investment Feasibility Analysis

    5.4 Pricing Analysis

    Chapter 6. Global Artifical Pancreas Device System (APDS) Market, by Type

    6.1 Introduction

    6.2 CTR (Control to Range) Systems

    Market Estimates & Forecast by region, 2020-2027

    Market Estimates & Forecast country, 2020-2027

    6.3 CTT (Control to Target) Systems

    Market Estimates & Forecast by region, 2020-2027

    Market Estimates & Forecast country, 2020-2027

    Chapter 7. Global Artifical Pancreas Device System (APDS) Market, by End User

    7.1 Introduction

    7.2 Hospitals

    Market Estimates & Forecast by region, 2020-2027

    Market Estimates & Forecast country, 2020-2027

    7.3 Medical Centers

    Market Estimates & Forecast by region, 2020-2027

    Market Estimates & Forecast country, 2020-2027

    7.4 Others

    Chapter 8. Global Artifical Pancreas Device System (APDS) Market, by Region

    8.1 Introduction

    8.2 Americas

    8.2.1 North America

    8.2.1.1 U.S.

    8.2.1.2 Canada

    8.2.2 South America

    8.3 Europe

    8.3.1 Western Europe

    8.3.1.1 Germany

    8.3.1.2 France

    8.3.1.3 Italy

    8.3.1.4 Spain

    8.3.1.5 U.K.

    8.3.1.6 Rest of Western Europe

    8.3.2 Eastern Europe

    8.4 Asia Pacific

    8.4.1 Japan

    8.4.2 China

    8.4.3 India

    8.4.4 Australia

    8.4.5 Republic of Korea

    8.4.6 Rest of Asia Pacific

    8.5 The Middle East & Africa

    8.5.1 The Middle East

    8.5.2 Africa

    Chapter 9. Company Landscape


    9.1 Introduction

    9.2 Market Share Analysis

    9.3 Key Development & Strategies

    Chapter 10. Company Profiles


    10.1 Medtronic plc

    10.1.1 Company Overview

    10.1.2 Product Overview

    10.1.3 Financials Overview

    10.1.4 Key Developments

    10.1.5 SWOT Analysis

    10.2 Bigfoot Biomedical

    10.2.1 Company Overview

    10.2.2 Product Overview

    10.2.3 Financial Overview

    10.2.4 Key Developments

    10.2.5 SWOT Analysis

    10.3 Johnson & Johnson

    10.3.1 Company Overview

    10.3.2 Product Overview

    10.3.3 Financial Overview

    10.3.4 Key Development

    10.3.5 SWOT Analysis

    10.4 Dexacom, Inc.

    10.4.1 Company Overview

    10.4.2 Technologys/Business Segment Overview

    10.4.3 Financial Overview

    10.4.4 Key Development

    10.4.5 SWOT Analysis

    10.5 CELLNOVO

    10.5.1 Company Overview

    10.5.2 Product Overview

    10.5.3 Financial overview

    10.5.4 Key Developments

    10.5.5 SWOT Analysis

    10.6 Tandem Diabetes Care, Inc.

    10.6.1 Company Overview

    10.6.2 Product Overview

    10.6.3 Financial Overview

    10.6.4 Key Developments

    10.6.5 SWOT Analysis

    10.7 Pancreum, Inc.

    10.7.1 Overview

    10.7.2 Product Overview

    10.7.3 Financial Overview

    10.7.4 Key Developments

    10.7.5 SWOT Analysis

    10.8 TypeZero Technologies, LLC

    10.8.1 Overview

    10.8.2 Product/ Technology Overview

    10.8.3 Financials

    10.8.4 Key Developments

    10.8.5 SWOT Analysis

    10.9 Beta Bionics

    10.9.1 Overview

    10.9.2 Product Overview

    10.9.3 Financials

    10.9.4 Key Developments

    10.9.5 SWOT Analysis

    10.10 F. Hoffmann-La Roche Ltd

    10.10.1 Overview

    10.10.2 Product Overview

    10.10.3 Financials

    10.10.4 Key Developments

    10.10.5 SWOT Analysis

    10.11 Inreda Diabetic B.V.

    10.11.1 Overview

    10.11.2 Product Overview

    10.11.3 Financials

    10.11.4 Key Developments

    10.11.5 SWOT Analysis

    10.12 Insulet Corp

    10.12.1 Overview

    10.12.2 Product Overview

    10.12.3 Financials

    10.12.4 Key Developments

    10.12.5 SWOT Analysis

    10.13 Others

    Chapter 11 MRFR Conclusion

    11.1 Key Findings

    11.1.1 From CEO’s View Point

    11.1.2 Unmet Needs of the Market

    11.2 Key Companies to Watch

    11.3 Prediction of the Artifical Pancreas Device System (APDS) Industry

    Chapter 12 Appendix

    LIST OF TABLES

    Table 1 Global Artifical Pancreas Device System (APDS) Market Synopsis, 2020-2027(USD Million)

    Table 2 Global Artifical Pancreas Device System (APDS) Market Estimates and Forecast, 2018– 2023, (USD Million)

    Table 3 Global Artifical Pancreas Device System (APDS) Market, by Region, 2020-2027, (USD Million)

    Table 4 Global Artifical Pancreas Device System (APDS) Market, by Type, 2020-2027, (USD Million)

    Table 5 Global Artifical Pancreas Device System (APDS) Market, by Type, 2020-2027, (USD Million)

    Table 6 Global Artifical Pancreas Device System (APDS) Market, by End-User, 2020-2027, (USD Million)

    Table 7 North America Global Artifical Pancreas Device System (APDS) Market, by Type, 2020-2027, (USD Million)

    Table 8 North America Global Artifical Pancreas Device System (APDS) Market, by End User, 2020-2027, (USD Million)

    Table 9 US Artifical Pancreas Device System (APDS) Market, by Type, 2020-2027, (USD Million)

    Table 10 US Artifical Pancreas Device System (APDS) Market, by Technology, 2020-2027, (USD Million)

    Table 11 US Artifical Pancreas Device System (APDS) Market, by End User, 2020-2027, (USD Million)

    Table 12 Canada Artifical Pancreas Device System (APDS) Market,by Type, 2020-2027, (USD Million)

    Table 13 Canada Artifical Pancreas Device System (APDS) Market, by End-User, 2020-2027, (USD Million)

    Table 14 South America Artifical Pancreas Device System (APDS) Market, by Type, 2020-2027, (USD Million)

    Table 15 South America Artifical Pancreas Device System (APDS) Market, by End-User, 2020-2027, (USD Million)

    Table 16 Europe Artifical Pancreas Device System (APDS) Market, by Type, 2020-2027, (USD Million)

    Table 17 Europe Artifical Pancreas Device System (APDS) Market, by End-User, 2020-2027, (USD Million)

    Table 18 Western Europe Artifical Pancreas Device System (APDS) Market, by Type, 2020-2027, (USD Million)

    Table 19 Western Europe Artifical Pancreas Device System (APDS) Market, by End-User, 2020-2027, (USD Million)

    Table 20 Eastern Europe Artifical Pancreas Device System (APDS) Market, by Type, 2020-2027, (USD Million)

    Table 21 Eastern Europe Artifical Pancreas Device System (APDS) Market, by End-User, 2020-2027, (USD Million)

    Table 22 Asia Pacific Artifical Pancreas Device System (APDS) Market, by Type, 2020-2027, (USD Million)

    Table 23 Asia Pacific Artifical Pancreas Device System (APDS) Market, by End-User, 2020-2027, (USD Million)

    Table 24 Middle East & Africa Artifical Pancreas Device System (APDS) Market, by Type, 2020-2027, (USD Million)

    Table 25 Middle East & Africa Artifical Pancreas Device System (APDS) Market, by End-User, 2020-2027, (USD Million)

    LIST OF FIGURES

    Figure 1 Research Process

    Figure 2 Segmentation for Global Artifical Pancreas Device System (APDS) Market

    Figure 3 Segmentation Market Dynamics for Global Artifical Pancreas Device System (APDS) Market

    Figure 4 Global Artifical Pancreas Device System (APDS) Market Share, by Type 2020

    Figure 5 Global Artifical Pancreas Device System (APDS) Market Share, by End-User, 2020

    Figure 6 Global Artifical Pancreas Device System (APDS) Market Share, by Region, 2020

    Figure 7 North America Artifical Pancreas Device System (APDS) Market Share, by Country, 2020

    Figure 8 Europe Artifical Pancreas Device System (APDS) Market Share, by Country, 2020

    Figure 9 Asia Pacific Artifical Pancreas Device System (APDS) Market Share, by Country, 2020

    Figure 10 Middle East & Africa Artifical Pancreas Device System (APDS) Market Share, by Country, 2020

    Figure 11 Global Artifical Pancreas Device System (APDS) Market: Company Share Analysis, 2020 (%)

    Figure 12 Medtronic plc: Key Financials

    Figure 13 Medtronic plc: Segmental Revenue

    Figure 14 Medtronic plc: Geographical Revenue

    Figure 15 Bigfoot Biomedical: Key Financials

    Figure 16 Bigfoot Biomedical: Segmental Revenue

    Figure 17 Bigfoot Biomedical: Geographical Revenue

    Figure 18 Johnson & Johnson::Key Financials

    Figure 19 Johnson & Johnson: Segmental Revenue

    Figure 20 Johnson & Johnson: Geographical Revenue

    Figure 21 Dexacom, Inc.: Key Financials

    Figure 22 Dexacom, Inc.: Segmental Revenue

    Figure 23 Dexacom, Inc.: Geographical Revenue

    Figure 24 CELLNOVO:Key Financials

    Figure 25 CELLNOVO: Segmental Revenue

    Figure 26 CELLNOVO. Geographical Revenue

    Figure 27 Tandem Diabetes Care, Inc.: Key Financials

    Figure 28 Tandem Diabetes Care, Inc.: Segmental Revenue

    Figure 29 Tandem Diabetes Care, Inc.: Geographical Revenue

    Figure 30 Pancreum, Inc.: Key Financials

    Figure 31 Pancreum, Inc.: Segmental Revenue

    Figure 32 Pancreum, Inc.: Geographical Revenue

    Figure 33 TypeZero Technologies, LLC: Key Financials

    Figure 34 TypeZero Technologies, LLC: Segmental Revenue

    Figure 35 TypeZero Technologies, LLC: Geographical Revenue

    Figure 36 Beta Bionics: Key Financials

    Figure 37 Beta Bionics: Segmental Revenue

    Figure 38 Beta Bionics: Geographical Revenue

    Figure 39 F. Hoffmann-La Roche Ltd: Key Financials

    Figure 40 F. Hoffmann-La Roche Ltd: Segmental Revenue

    Figure 41 F. Hoffmann-La Roche Ltd: Geographical Revenue

    Figure 42 Inreda Diabetic B.V.: Key Financials

    Figure 43 Inreda Diabetic B.V.: Segmental Revenue

    Figure 44 Inreda Diabetic B.V.: Geographical Revenue

    Figure 45 Insulet Corp: Key Financials

    Figure 46 Insulet Corp: Segmental Revenue

    Figure 47 Insulet Corp: Geographical Revenue